Cochlear Completes Recruitment for Global Pivotal Program Evaluating Fully Implantable Hearing Technology Cochlear has announced the completion of patient recruitment for its worldwide pivotal clinical trial program evaluating fully implantable…
Meitheal Pharmaceuticals Announces FDA Approval of High-Concentration Interchangeable YUSIMRY Biosimilar to Humira Meitheal Pharmaceuticals, Inc., a Chicago-based fully integrated biopharmaceutical company focused on the development and commercialization of generic injectables,…
Diagnostic Imaging Centers of Texas Expands VoxNeuro Collaboration to Enhance Post-Trauma Patient Evaluation Diagnostic Imaging Centers of Texas (DICOT) has announced an expanded collaboration with VoxNeuro Inc. designed to support…
Alcon Launches Systane PRO Preservative-Free in Canada With Up to 12 Hours of Dry Eye Relief Alcon, a global leader in eye care, has announced the Canadian launch of Systane®…
Kerecis Launches Compact Fish-Skin Platform to Improve Deep Wound Management and Reduce Graft Waste Kerecis, a company focused on tissue regeneration using sustainably sourced fish skin, has announced the launch…
Avenzo Therapeutics Strengthens Executive Leadership With Appointments of Annie Chang and Aaron Hasnain Avenzo Therapeutics, Inc., a clinical-stage biotechnology company focused on developing next-generation oncology therapies, has expanded its executive…
Biodextris Appoints Clement Fourny as CEO to Lead Next Phase of Biologics CDMO Growth Biodextris, a Laval, Quebec-based biologics contract development and manufacturing organization (CDMO), has appointed Clement Fourny as…
SCIEX Expands BioPhase 8800 Capabilities to Support Faster, More Automated CE Workflows SCIEX, a Danaher company and a provider of analytical technologies for the life sciences, has announced new capillary…
Bayer’s Lynkuet Receives FDA Priority Review for Vasomotor Symptoms Associated With Breast Cancer Endocrine Therapy Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental…
Circle Pharma Strengthens Leadership Team to Advance Targeted Macrocycle Cancer Pipeline Circle Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation targeted macrocycle therapeutics for cancer, has announced two…
Bristol Myers Squibb Reports Phase 3 EXCALIBER-RRMM Results Showing Higher MRD-Negative Responses With ZENBEXUS in Relapsed or Refractory Multiple Myeloma Bristol Myers Squibb (NYSE: BMY) has announced the first presentation…
Lōkahi Therapeutics Expands ai2 Pipeline Program Through Partnership With Pepperdine E2B Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), has announced a new collaboration with Pepperdine E2B™ (Education to…